2,6-difluoro-3,4-dihydroxyphenylalanine has been researched along with Movement Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pretze, M; Wängler, B; Wängler, C | 1 |
1 review(s) available for 2,6-difluoro-3,4-dihydroxyphenylalanine and Movement Disorders
| Article | Year |
|---|---|
6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Disorders; Radioactive Tracers; Radionuclide Imaging | 2014 |